Promising Results in Mice Prompt Human Trial of Novel Lymphoma Vaccine Promising Results in Mice Prompt Human Trial of Novel Lymphoma Vaccine

An in situ vaccine (ISV) combined with immune stimulants and radiotherapy showed efficacy in mice, prompting a phase 1 trial of patients with advanced indolent non-Hodgkin ' s lymphoma (INHL), researchers say.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news